Nasdaq: THEO

BOA Acquisition Corp. II (THEO)

BOA Acquisition Corp. II is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker THEO. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
THEO
Exchange
Nasdaq
SEC CIK
2080216
Official filings
SEC EDGAR

Research THEO

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is BOA Acquisition Corp. II's stock ticker?

BOA Acquisition Corp. II trades under the ticker symbol THEO on Nasdaq. Its SEC Central Index Key (CIK) is 2080216.

Where can I read BOA Acquisition Corp. II's SEC filings?

The THEO SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports BOA Acquisition Corp. II has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze THEO's financial statements?

The THEO Financials page shows BOA Acquisition Corp. II's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does THEO compare with its peers and the market?

The THEO Peer Comparison page lines BOA Acquisition Corp. II up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.